Children as young as 13 treated for 'ketamine bladder' at first UK paediatric clinic
Alder Hey children's hospital in Liverpool has opened the UK's first ketamine clinic for young people after a surge in severe urology problems linked to sustained use of the drug, with patients as young as 13 and most of them girls from deprived areas.
Children as young as 13 are being referred to a specialist clinic in the UK for a devastating bladder condition linked to sustained ketamine use, in a development that has prompted medics to open the country's first dedicated service for young people affected by the drug.
The clinic at Alder Hey children's hospital in Liverpool was established in response to a surge in urology problems associated with ketamine addiction. It is the first facility of its kind in the UK for paediatric patients, and its caseload has drawn attention to a condition that can cause chronic pain and, in severe cases, require dialysis.
Ketamine-induced uropathy, the clinical term for the damage caused by prolonged use of the drug, is described by specialists as severe and painful. The condition affects the urinary tract and can lead to lasting bladder dysfunction, with the most serious presentations requiring intensive treatment.
An analysis of the first patients seen at the Liverpool service indicates that the majority are girls, and that most come from deprived areas. The findings suggest the problem is not confined to a single demographic and that deprivation may be a factor in how young people encounter and continue to use the drug.
The opening of the Alder Hey clinic reflects growing concern among paediatric urologists and addiction specialists about the scale of harm caused by ketamine, which is used recreationally and has long been associated with bladder damage in adult users. The arrival of patients as young as 13 at a specialist referral point indicates that the issue now extends into adolescence.
Ketamine bladder is characterised by urinary frequency, urgency, pain and, in advanced cases, reduced bladder capacity and kidney complications. Treatment typically involves stopping the drug, but recovery is not guaranteed and some patients require ongoing urological care. In the most severe cases, dialysis may be needed if kidney function is compromised.
The clinic's creation follows a pattern seen in other parts of the UK, where rising ketamine use has placed pressure on urology services. However, the Liverpool service is the first to focus specifically on children and young people, a group that may face particular barriers to seeking help, including stigma and a lack of awareness that the drug can cause lasting physical harm.
Medics involved in the service have described the condition as devastating for young patients and their families. The combination of chronic pain, repeated hospital appointments and potential long-term organ damage places a significant burden on children at a formative stage of their lives.
The research into the first patients at the clinic also highlights the importance of early intervention. By identifying cases in adolescence, clinicians hope to prevent progression to end-stage bladder or kidney disease, which can require surgery or transplantation.
Public health specialists have pointed to the need for better education about the risks of ketamine, particularly among teenagers and young adults. The drug's reputation as a party substance has often overshadowed its potential to cause serious urological damage, and awareness campaigns have lagged behind its rising popularity.
The concentration of cases among girls and young people from deprived backgrounds raises questions about access to support services and the social factors that shape drug use. Deprivation can be associated with limited recreational opportunities, mental health pressures and reduced access to early healthcare, all of which may contribute to sustained use and delayed presentation.
The Alder Hey clinic is expected to provide a model for other regions as health authorities assess the extent of ketamine-related harm among young people. Its patient data will also contribute to a clearer picture of how the condition develops and which interventions are most effective.
For now, the emergence of patients as young as 13 at a specialist bladder clinic serves as a stark indicator of the toll ketamine can take. The condition is preventable if use stops early enough, but once damage is established, treatment becomes more complex and the prospects for full recovery less certain.
4
